These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23255321)

  • 1. Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts.
    Rao-Bindal K; Rao CK; Yu L; Kleinerman ES
    Pediatr Blood Cancer; 2013 Apr; 60(4):575-9. PubMed ID: 23255321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
    Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
    Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
    Gordon N; Kleinerman ES
    Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
    Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
    Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas expression in lung metastasis from osteosarcoma patients.
    Gordon N; Arndt CA; Hawkins DS; Doherty DK; Inwards CY; Munsell MF; Stewart J; Koshkina NV; Kleinerman ES
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):611-5. PubMed ID: 16282894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
    Gordon N; Kleinerman ES
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
    Huang G; Nishimoto K; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
    Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts.
    Rao-Bindal K; Zhou Z; Kleinerman ES
    Cell Death Dis; 2012 Aug; 3(8):e369. PubMed ID: 22875006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.
    Huang G; Nishimoto K; Zhou Z; Hughes D; Kleinerman ES
    Cancer Res; 2012 Feb; 72(4):908-16. PubMed ID: 22186140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases.
    Koshkina NV; Rao-Bindal K; Kleinerman ES
    Cancer; 2011 Aug; 117(15):3457-67. PubMed ID: 21287529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
    Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
    Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
    Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
    Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
    [No Abstract]   [Full Text] [Related]  

  • 16. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas expression inversely correlates with metastatic potential in osteosarcoma cells.
    Worth LL; Lafleur EA; Jia SF; Kleinerman ES
    Oncol Rep; 2002; 9(4):823-7. PubMed ID: 12066216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.
    Duan X; Jia SF; Koshkina N; Kleinerman ES
    Cancer; 2006 Mar; 106(6):1382-8. PubMed ID: 16453328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
    Jia SF; Guan H; Duan X; Kleinerman ES
    J Exp Ther Oncol; 2008; 7(2):89-97. PubMed ID: 18771083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.